Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
American College of Physicians Issues New Mammography Screening Guidelines for Women
00

American College of Physicians Issues New Mammography Screening Guidelines for Women

Apr 19, 2026

The American College of Physicians has issued new mammography screening guidelines for breast cancer that recommend all average-risk women ages 50 to 74 receive biennial screening mammography. For women between ages 40 and 49, the ACP recommends individualized decision-making, advising these women to discuss with their doctors both their personal risk for breast cancer and the benefits and harms of screening mammography. The guidance distinguishes between age groups, establishing a clear screening protocol for older women while emphasizing shared decision-making for younger women where the risk-benefit calculus may vary more by individual circumstances.

New ACP Mammography Screening Guidelines

  • ▪The American College of Physicians (ACP) issued new mammography screening guidance for breast cancer

Age-Specific Screening Recommendations

  • ▪The American College of Physicians recommends that females between the ages of 40 and 49 should discuss with their doctor their risk for breast cancer
  • ▪The American College of Physicians recommends that all average-risk females ages 50 to 74 should receive biennial screening mammography for breast cancer

Perspective of American College of Physicians

  • ▪The American College of Physicians' guidance prioritizes shared decision-making between doctors and patients for women ages 40-49 regarding mammography screening
  • ▪The American College of Physicians' mammography recommendations aim to balance the benefits of early cancer detection against potential harms of screening

1 source

Medicalxpress
New guidance says all average-risk females aged 50–74 should undergo biennial mammography screening
View source article

Story comments

Loading comments…

Related entities

Preventive medicineWomen's health

Topics

Drug Approval and Clinical TrialsPublic healthcare